The "Autoimmune Hepatitis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 10+ companies and 10+ pipeline ...

The European Medicines Agency said on Tuesday that it has withdrawn the marketing authorisation for Abbvie's hepatitis C drug ...

The Hepatitis E drugs in development market research report provides comprehensive information on the therapeutics under development for Hepatitis E, complete with analysis by stage of development, ...

The Alcoholic Hepatitis drugs in development market research report provides comprehensive information on the therapeutics under development for Alcoholic Hepatitis, complete with analysis by stage of ...

Less than three years after Sovaldi’s launch, hepatitis C (hep C) treatment has been transformed, thanks to the drug and rapidly-evolving competition in the field. But only a small percentage of ...

Less than half of those who tested positive for HIV in Pretoria were aware of their HIV status. As such they would not have ...

This has long been a problem in South Africa and appears to be getting worse. Research conducted in eThekwini in 2013 found that 17% of injecting drug users were HIV-positive. According to the new ...

Hepatitis B affects almost 300 million people worldwide, according to GSK, and while nucleoside/nucleotide analogue (NA) drugs to treat it are available – such as Gilead’s polymerase inhibitor ...